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Designh i g h l i g h t s
 A review of technical aspects of transcranial electrical stimulation (tES) techniques.
 Recommendations for safe and replicable application of tDCS and other tES methods.
 Discussion of state-of-the-art methodology and design considerations in tES.
a b s t r a c t
Transcranial electrical stimulation (tES), including transcranial direct and alternating current stimulation
(tDCS, tACS) are non-invasive brain stimulation techniques increasingly used for modulation of central
nervous system excitability in humans. Here we address methodological issues required for tES applica-
tion. This review covers technical aspects of tES, as well as applications like exploration of brain physi-
ology, modelling approaches, tES in cognitive neurosciences, and interventional approaches. It aims to
help the reader to appropriately design and conduct studies involving these brain stimulation techniques,
understand limitations and avoid shortcomings, which might hamper the scientific rigor and potential
applications in the clinical domain.
 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).esearch,
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Transcranial direct current stimulation (tDCS) was re-
introduced as a non-invasive brain stimulation (NIBS) technique
applicable in humans approximately 15 years ago (Priori et al.,
1998; Nitsche and Paulus, 2000). Its principal mechanism of action
is a subthreshold modulation of neuronal membrane potentials,
which alters cortical excitability and activity dependent on the cur-
rent flow direction through the target neurons (Purpura and
McMurtry, 1965). Other biological effects of the electric field are
also likely relevant (changes in neurotransmitters, effects on glial
cells and on microvessels, modulation of inflammatory processes).
In analogy to pharmacological neuromodulators, tDCS does not
induce activity in resting neuronal networks, but modulates spon-
taneous neuronal activity (Fritsch et al., 2010). Consequently, the
amount and direction of effects critically depend on the previous
physiological state of the target neural structures (Antal et al.,
2014a; Thirugnanasambandam et al., 2011) In this sense, tDCS,
transcranial alternating current stimulation (tACS) and transcra-nial random noise stimulation (tRNS) represent neuromodulatory
techniques. They do not induce massive synchronized discharge
of action potentials as TMS or paired associate stimulation (PAS)
do. DCS changes the threshold for discharge of stimulated neurons,
thus changing the likelihood of their discharge (Nitsche and Paulus,
2000; Nitsche et al., 2003; Nitsche and Paulus, 2001; Fritsch et al.,
2010). DCS at intensities comparable to those modelled in humans
does not induce LTP in slices of mouse primary motor cortex. How-
ever, when combined with a second input, for example thalamo-
cortical stimulation, DCS results in powerful elicitation of LTP
(Fritsch et al., 2010). This basic science work suggested that, in
human application, LTP-like effects may be better accomplished
by pairing DCS with the behavior intended to modulate. Thus,
DCS effects depend on the baseline status of the brain at the time
of its application. This dependency could possibly influence
interindividual variability in DCS effects previously reported
(López-Alonso et al., 2014; Wiethoff et al., 2014) and the fact that
differences in experimental protocols such as stimulation intensity
or use of different versions of the same or different behavioural
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et al., 2013). In the case of tACS, the neuromodulatory intent is
to entrain brain oscillations (Antal et al., 2008; Ali et al., 2013;
Neuling et al., 2013; Cecere et al., 2014; Helfrich et al., 2014b). In
case of such entrainment, one oscillation, e.g. the tACS sine wave,
modulates the power and/or phase of another oscillation, e.g. an
endogenous brain oscillation.
In the following sections, we will discuss technical aspects of
tDCS and related techniques, covering basic methodological issues,
including modelling aspects, but also interventional approaches in
cognitive neurosciences and clinical trials. We hope that hereby
this review will contribute to enhancing the methodological qual-
ity of research within this emerging field.
2. Transcranial direct current stimulation
tDCS is a tES technique that involves the application of a weak
direct electrical current (e.g., 1–2 mA) scalp through two or more
electrodes placed on the scalp (Priori et al., 1998; Nitsche and
Paulus, 2000).
2.1. Selecting and preparing electrodes and contact medium
The purpose of electrodes in tDCS is to facilitate delivery of cur-
rent from the stimulation device to the scalp. With rigorous control
of electrode selection and preparation, along with adherence to
established tDCS protocols, operator training, and use of certified
devices, teams of clinical trial researchers have reported applica-
tion of thousands of tDCS sessions without any skin injury
(Brunoni et al., 2011b, 2013b; Kalu et al., 2012; Loo et al., 2012;
Fertonani et al., 2015). The electrode assembly most commonly
used for tDCS comprises (1) a metal or conductive rubber elec-
trode, (2) an electrode sponge, and (3) an electrolyte-based contact
medium (e.g., saline, gel, or conductive cream) to facilitate delivery
of current to the scalp, as well as (4) any materials used to shape
these components or otherwise direct current flow (plastic casing,
rivets).
During tDCS, the metal or conductive rubber electrode is the
site of electrochemical reactions (Merrill et al., 2005) and should
not directly contact the skin. Rather, an electrolyte is used as a buf-
fer between the electrode and the skin – with sufficient electrolyte
volume preventing chemicals formed at the electrode from reach-
ing the skin (Minhas et al., 2010; Palm et al., 2014). The electrolyte
can be placed in a sponge encasing the electrode (i.e., saline) or, in
the case of electrode cream, placed directly on the electrode sur-
face. However, in the case of saline, oversaturation of the electrode
sponge significantly undermines the reproducibility of tDCS appli-
cation and effects. When sponges are over-saturated, saline is
evacuated from the sponge and covers an area of the scalp outside
of the surface area electrode sponge. Rather than delivering current
through a specified surface area on the scalp under the electrode
(e.g., 5  5 cm), the electrode surface area and area of current
delivery now encompasses the entire area of the scalp that is cov-
ered in saline. This creates an amorphous area of current delivery
that is not reproducible within or between subjects. It is important
to obtain good contact under, and only under, the electrode with
the electrode sufficiently, but not overly saturated. Methods allow-
ing quantification of saline (e.g., syringes) can assist in achieving a
consistent and appropriate amount of contact medium.
Consistent with issues introduced by oversaturation of sponges,
the shape/size of electrodes/sponges significantly alter the distri-
bution of current delivered to the scalp and the brain (Minhas
et al., 2011; Kronberg and Bikson, 2012). At a constant current
intensity level (e.g., 1 mA), increases in electrode size or differences
in electrode assembly shape result in differences in the distribution
of the current across the surface area of the scalp, resulting in dif-ferences in the distribution of current throughout the brain
(Minhas et al., 2011; Kronberg and Bikson, 2012). Thus, it is critical
for investigators to consistently report not only the current inten-
sity applied and the amount of contact medium used, but also the
shape and size of the electrode assembly.
2.2. Selecting and preparing electrode placement
Another critical consideration for tDCS is determining where to
place electrodes on the head. Studies monitoring physiological
changes following tDCS and computational modeling studies of
predicted current flow demonstrate that the relative location of
electrodes results in significant differences in where and how
much current is delivered to the brain (Minhas et al., 2012;
Kessler et al., 2013; Woods et al., 2015). For example, Nitsche
and Paulus (2000) demonstrated that relative differences in elec-
trode locations altered whether or not tDCS impacted TMS gener-
ated motor-evoked potentials (MEPs). Numerous modeling
studies have demonstrated significant differences between relative
locations of electrodes, with results varying from stimulation of the
whole brain to more selective stimulation of particular lobes of the
brain (Minhas et al., 2012; Kessler et al., 2013; Woods et al., 2015).
Woods et al. (2015) further demonstrated that as little as 1 cm of
movement in electrode position significantly altered the distribu-
tion of predicted current flow in the brain, as well as the intensity
of stimulation in specific brain regions Computational modeling
(discussed in detail in a later section) can be a useful tool for the
a priori design of tDCS electrode positions for a given study. In this
same context, the importance of electrode location also highlights
yet another critical consideration, preparation of a stable electrode
placement on the head.
As head size and shape vary from person to person, it is impor-
tant to use a method for common localization of electrode position.
There are several methods for addressing this issue: (1) Interna-
tional 10–20 (or 10–5) electrode placement System (Klem et al.,
1999; Oostenveld and Praamstra, 2001), or another gross anatom-
ical coordinate system (Seibt et al., 2015), (2) neuronavigation sys-
tems (e.g., MRI guided; Feurra et al., 2011a,b, 2013; Santarnecchi
et al., 2014), or (3) physiology-based placement (e.g., TMS gener-
ated MEPs). At present, physiology based placement can only be
performed for motor and other primary cortices (e.g., sensory).
However, further options may become available in the future
(e.g., TMS-EEG methods). Regardless, these methods can be used
to reproducibly center each electrode on the head, accommodating
varied head shape or size.
Once desired locations are identified, the electrode assembly
must be affixed to the head for delivery of current. Non-
conductive headgear used to position the electrodes on the body
or scalp (e.g., elastic straps) are not included in the electrode
assembly but are critical for appropriate electrode placement
(Woods et al., 2015). For tDCS using sponge-covered electrodes,
elastic straps are the most commonly used headgear for electrode
placement. If these straps are under- or over-tightened, electrodes
have a high tendency to move over the course of a tDCS session.
Thus, the distribution of current delivery changes over the duration
of a tDCS session (Woods et al., 2015). This too undermines tDCS
replicability. Furthermore, if electrode straps are over-tightened,
there is an increase in the probability of evacuation of saline from
the electrode sponges. Regardless, the contour at the base of the
skull below the inion and the flat of forehead provide for stable
placement of a strap around the head. For participants with long
hair, placement of the back of the strap under the hairline also
improves stability of the strap preparation, whereas placement
over the hair leads to a high probability of upward drift of the strap
and the electrodes placed on the head. Use of cross straps over the
head should also avoid over-tightening of the cross-strap to avoid
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this tendency, but may be uncomfortable to participants. If
under-chin straps are used, these should be used for all partici-
pants to maintain consistency of participant experience in the
study.
2.3. Selecting a stimulation protocol
If the purpose is to modulate neurophysiological measures (e.g.,
MEP amplitudes) for resting motor cortex stimulation in healthy
young humans (1 mA intensity, electrode size 35 cm2), tDCS for
4 s induces acute excitability alterations, which do not result in
after-effects (Nitsche and Paulus, 2000). Short-lasting after-
effects for up to 10 min are accomplished by 5 and 7 min stimula-
tion, whereas 9 min stimulation of the motor cortex under the
cathode electrode, and 13 min stimulation under the anode elec-
trode result in after-effects lasting for approximately 1 h
(5  7 cm electrodes, motor cortex-contralateral supraorbital ridge
electrode arrangement (Nitsche and Paulus, 2000, 2001; Nitsche
et al., 2003); for an overview about the physiological foundation
of after-effects see Stagg and Nitsche (2011). Further extension of
stimulation duration and/or intensity will not necessarily result
in a relative increase, but can invert stimulation effects
(Batsikadze et al., 2013; Monte-Silva et al., 2013b). For the induc-
tion of relevantly longer-lasting tDCS effects, spaced stimulation
with intervals 630 min is suited (Monte-Silva et al., 2013b;
Goldsworthy et al., 2014). It remains to be determined to what
extent parameters of stimulation that modify physiological
responses to TMS stimulation impact motor behaviour or can be
applied with similar success to other brain regions and behaviours.
While these stimulation parameters can serve as a rule of thumb
for tDCS of other areas, participant groups, and experimental condi-
tions, a one-to-one transferability of effects found in studies of
motor cortices cannot be taken for granted due to state-
dependency of tDCS effects, anatomical differences, and other fac-
tors (Nitsche and Paulus, 2000; Kessler et al., 2013; Gill et al.,
2014). Thus, if no reference study exists for a specific experimental
protocol, titration of stimulation parameters is recommended
(Boggio et al., 2006; Iyer et al., 2005a; Cuypers et al., 2013). Further-
more, these stimulation protocols elicit respective effects at the
group level. Individual efficacy varies considerably (Wiethoff et al.,
2014). Individual adjustment of stimulation protocols due to state,
and anatomical factors, such as electrode-brain-distance, and corti-
cal folding, might be an attractive solution in future studies.
The above-mentioned electrodes will result in relatively wide-
spread stimulation of brain regions, physical, and probably also
physiological effects (Minhas et al., 2010; Kuo et al., 2013). If less
widespread effects are intended, different options do exist. Efforts
to improve focality of DCS are under way, like high-definition (HD)
tDCS, a small central electrode positioned over the target is sur-
rounded by 4 return electrodes (Minhas et al., 2010). Other options
include decreasing target electrode size, while keeping current
density constant, increasing return electrode size (Nitsche et al.,
2007a), or moving the return electrode to an extracephalic region,
which might require higher stimulation intensity (Moliadze et al.,
2010). In addition, other work has investigated the benefit of per-
sonalized electrode shape and size for stimulation of desired brain
regions (Tecchio et al., 2013). However, if these approaches induce
different current flow direction, physiological effects might not be
identical, as distribution of currents and behavioural effects of
tDCS critically depends on the relation between current flow direc-
tion and neuronal orientation in the target areas (Kabakov et al.,
2012). Furthermore, reduction of electrodes size might over-
proportionally reduce current flow into the brain, thus an adjust-
ment of current intensity to slightly larger relative values might
be required (Miranda et al., 2009). That said, one of the useful fea-tures of tDCS, particularly in relation to potential therapeutic appli-
cations, may be its lack of focality. On the other hand, it should be
recognized that if the attempt is to deliver more focal stimulation,
the choice of TMS with a figure-of-eight magnetic coil is likely to
induce much more focal currents than tDCS.
2.4. Use of blinding and sham
The usual approach of blinding participants for plasticity-
inducing protocols is to apply a ‘‘sham” stimulation protocol,
which encompasses ramping stimulation up and down like in the
real stimulation condition, but to stimulate with the target inten-
sity only for a few seconds. Participants will feel the initial itch-
ing/tingling sensation, but the stimulation duration is too short
to induce after-effects. For 1 mA tDCS with an electrode size of
25 cm2, this method has been shown to reliably blind participants
(Gandiga et al., 2006; Ambrus et al., 2012). Stronger stimulation
will induce larger sensations, and thus compromise blinding, espe-
cially under repeated measures conditions (O’Connell et al., 2012;
Palm et al., 2013). In parallel studies, this might however not be a
relevant problem (Russo et al., 2013). Alternative approaches are
application of topical anaesthetics to abolish skin sensations
(Guleyupoglu et al., 2014) or, probably much more valuable, an
active control condition (i.e., stimulation over an area irrelevant
for the task under study). Since the occurrence of skin damage
seems to be not reliably associated with cutaneous sensation
(Palm et al., 2008), local anaesthetics should not put participants
specifically at risk. Blinding of the experimenter with regard to
the specific stimulation protocol is accomplished by use of stimu-
lators that include a sham stimulation function, thus keeping the
experimenter unaware of the specific stimulation condition. Even
here, however, the presence of skin erythema, which is due to
tDCS-induced vasodilation (Durand et al., 2002), can compromise
blinding. Skin erythema is reliably reduced by acetylsalicylate, or
topical application of ketoprofen (Durand et al., 2002; Guarienti
et al., 2014). Thus, for reliable double blinding, a couple of
approaches are available, which should be chosen carefully due
to the specific experimental design. Other approaches for testing
the specificity of the effects are assessing the effects of opposite
stimulation polarities, or testing the effect on different central ner-
vous system areas.
Overall, when the goal is to demonstrate that stimulation
applied over one cortical region induces a particular effect, an
active control in which a different brain region is stimulated pro-
vides a strong foundation for interpretation of results in this con-
text. If the goal is to demonstrate a polarity-specific effect, use of
the opposite polarity for the same stimulated region is an appropri-
ate control choice. The choice of the control has a profound impact
on the conclusion that can be drawn from a particular study and
should be highly hypothesis-driven.
2.5. Safety versus tolerability
It is important to discern between tolerability and safety
aspects in a strict sense. Tolerability refers to the presence of
uncomfortable and unintended effects (e.g. tingling, and itching
sensation under the electrodes), which in case of tDCS are however
not inducing structural or functional damage, whereas safety refers
to damaging effects. Comfort ratings for presently used protocols
show a favourable tolerability profile. Most often reported effects
are tingling and itching sensations under the electrodes, headache,
and tiredness (Poreisz et al., 2007; Fertonani et al., 2015). The sen-
sation of phosphenes elicited by abrupt current on- or offset is
avoided by ramping current intensity. Erythema under the elec-
trodes are caused by tDCS-induced vasodilation, and thus are not
a safety issue (Durand et al., 2002). For safety aspects in a strict
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cortex stimulation protocols introduced by Nitsche and colleagues
(Nitsche and Paulus, 2001; Nitsche et al., 2003). Furthermore,
unlike repetitive TMS (rTMS), no cases of seizure induction have
been reported to date. In vivo rat models favour a safety margin
of about 2 orders of magnitude of the currently used protocols
(Liebetanz et al., 2009). However, stimulation over holes or fissures
of the cranial bone, which results in local enhancement of current
density, should be approached with caution (Agnew and McCreery,
1987). Skin damage has been reported occasionally (Palm et al.,
2008), but was in most cases associated with protocol shortcom-
ings, like drying of the contact media under the electrodes. In a
recently conducted study, tap water increased the risk of skin dam-
age (i.e., burns) as compared to physiological saline solution. Thus,
tap water as a contact medium should be avoided. For use of elec-
trode cream, a sufficiently thick film, which prevents direct contact
between skin and electrodes, is mandatory (Nitsche et al., 2010;
Voss et al., 2014). Thus, electrode gels are not appropriate as a con-
tact medium for conventional flat electrodes, as they do not pro-
vide a sufficiently thick film for necessary electrode to scalp
spacing – unless a container is used to control thickness and elec-
trode–skin distance. Functional safety encompasses the induction
of cognitive, behavioural, or other disturbances, which are not
intended by, or can be derived from the principle physiological
effect of tDCS, and are not self-limiting. In healthy populations
no specific effects of this kind were described with currently used
protocols. When present, decreases in performance have been
transient (Antal et al., 2004a; Iuculano and Cohen Kadosh, 2013).
Taken together, customarily applied tDCS protocols using rela-
tively well-defined electrodes, stimulus durations and intensities
seem to be safe, and well tolerated. Moreover, modelling studies
also showed that the use of an extracephalic electrode on the
shoulder should not influence cardiac or brainstem activities
(Parazzini et al., 2013a,b). This assumption does, however, not nec-
essarily apply for any tDCS protocol, independent from current
intensity, and stimulation duration, and without regard for inclu-
sion/exclusion criteria. Thus, any general statements that ‘‘tDCS
is safe” independent of protocol characteristics should be entirely
avoided. Moreover, this assumption is only valid if common exclu-
sion criteria for tDCS/NIBS (metal in the head, pacemaker, no stim-
ulation over fissures, or cranial holes, causing locally enhanced
current density) are followed. Special consideration should also
be given when determining safety and tolerability in children,
where parameters safely used in adults may have a different safety
and tolerability profile (Minhas et al., 2012; Kessler et al., 2013). On
the other hand, it is important not to confuse calls for excessive
caution in susceptible populations (children, brain injury) with
the existence of any data suggesting safety risks.
2.6. Considerations for transcutaneous spinal DC stimulation (tsDCS)
In 2008, Cogiamanian et al. found that weak DC delivered over
the dorsal spinal cord modulates in a polarity-dependent manner
the amplitude of the somatosensory evoked potential (SEPs) eli-
cited by tibal nerve stimulation (Cogiamanian et al., 2008). The
effect was specific because SEPs elicited by median nerve stimula-
tion were not influenced by thoracic transcutaneous spinal DC
stimulation. Several further studies replicated the observation that
weak DC delivered over the spinal cord can influence different
physiological variables of spinal cord function in humans and ani-
mals, both intact and injured (for a review see Priori et al. (2014).
In applying tsDCS, researchers used certain key technical fea-
tures (Toshev et al., 2014). For lumbar spinal cord modulation, the
electrodes (measuring about 5  7 cm) are usually placed over the
spinous process of the tenth thoracic vertebra and above the right
shoulder (Cogiamanian et al., 2008, 2011; Lamy et al., 2012; Lamyand Boakye, 2013). For cervical spinal cord modulation, one elec-
trode was positioned on the seventh cervical vertebra and the other
on the anterior part of the neck (Lim and Shin, 2011). An influential
variable that needs to be systematically investigatedwhen applying
tsDCS is the effect of electrode positioning on the arm or elsewhere
(see below). Also, stimulation intensity and duration were kept rel-
atively constant across the various studies from different groups:
intensities between 2 and 2.5 mA were usually applied for
15/20 min. Like tDCS, spinal DC often elicits short-lasting tingling
sensations when stimulation begins and ends, and sometimes red-
ness under the electrode. The effect of polarity on physiology is
complex (Priori et al., 2014). In general, in humans it can be
assumed that thoracic transcutaneous DC under the anode elec-
trode decreases responses involving spinal tract compartments
below the stimulating electrode and increases segmental reflex
responses, whereas the cathode electrode induces opposite effects.
This polarity convention (opposite from conventional tDCS) sim-
plistically appears to follow that expected for long axons, but could
also reflect the underlying neuronal morphology. Thus, the polarity
of the electrodes is critical for physiological effects.
Like in cortical tDCS, the position of the return electrode may
influence the effects of spinal DC stimulation. Parazzini et al.
(2014b) assessed three electrode montages in a modeling study,
with the anode always over the spinal process of the tenth thoracic
vertebra and the cathode: (1) on the right arm, (2) on the abdom-
inal wall 2 cm above the umbilicus on the median line and (3) on
the vertex. Within the spinal cord, the electric field was primarily
directed longitudinally along the vertebral column. On transverse
spinal cord sections, current density distributed uniformly. This
finding suggests that the ventral (motor) and dorsal (sensory) axo-
nal tracts receive identical electric field strength. The return elec-
trode position over the right arm results in current prevailing at
the thoracic level. Conversely, the return electrode position over
Cz results also in supra-spinal effects at the bulbar level (see also
Priori et al. (2014) for a discussion). Hence, the type of montage
should be selected according to the aim of the study.
2.7. Considerations for cerebellar tDCS
When delivering cerebellar tDCS (ctDCS) it is important to con-
sider which region of the cerebellum is being targeted as well as
the underlying cellular morphology (Rahman et al., 2014). Similar
to the neuromodulation of any other CNS structure, the focality of
ctDCS effects is presumably relatively limited, however recent
studies aimed also for relatively focal stimulation. In this section
we will describe the two most common electrode montages uti-
lized in different laboratories (for a detailed review on the tech-
nique and cerebellar tDCS applications see Ferrucci and Priori,
2014a; Grimaldi et al., 2014; Priori et al., 2014).
2.7.1. Targeting the whole cerebellum
This montage includes the use of a large electrode measuring
about 7  5 cm (area 35 cm2). One electrode is centered horizon-
tally on the median line over the whole cerebellum (1–2 cm below
the inion) with its lateral borders about 1 cm medially to the bilat-
eral mastoid apophysis. The second electrode is placed over one of
the buccinator muscles, the right shoulders or over the scalp
(Ferrucci et al., 2015). tDCS over the whole cerebellum modulates
implicit learning (Ferrucci et al., 2013), working memory (Ferrucci
et al., 2008), emotion recognition (Ferrucci and Priori, 2014b) and
pain perception (Bocci et al., 2015) in healthy subjects.
2.7.2. Targeting the cerebellar hemispheres
This montage includes two 5  5 cm electrodes (area 25 cm2 for
each electrode). One electrode is centered 3 cm lateral to the inion
with half of the electrode covering an imaginary line above the
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trode will have the medial border at 0.5 cm from the inion, with
the superior and inferior border 2.5 cm above and below the inion.
The second electrode is placed ipsilaterally over the face cheek.
Thus, a 5  5 cm electrode lays 1 or 2 cm behind the angle of the
mouth with the midline crossing an imaginary line going from
the mouth angle to the tragus (Grimaldi et al., 2014; Celnik, 2015).
The same precautions for electrode preparation and placement
described above should also be observed for cerebellar tDCS. The
cerebellar electrode is typically fixed with a headband or ace wrap
in the axial plane, whereas the face electrode is fixed with a head-
band on the coronal or vertical plane (Galea et al., 2009; Cantarero
et al., 2015). Both electrodes are connected to a standard tDCS
stimulator, delivering DC for the desired amount of time (typically
15–25 min), at an intensity ranging from 1 to 2 mA. Modeling stud-
ies show that, using the whole cerebellummontage with the return
electrode over the right shoulder, cerebellar tDCS targets the pos-
terior cerebellum in the adult bilaterally, with a slight spread to
the brainstem in children (Parazzini et al., 2014c); while the lateral
cerebellar montage affects only one hemisphere with little spread-
ing to other regions (Rampersad et al., 2014). The validity of these
modeling results should be evaluated with human experiments.
2.8. Selecting a stimulator
Currently a limited set of certified tDCS-stimulators are avail-
able (e.g., produced/distributed by Brainstim, Magstim, Neuroconn,
Neuroelectrics, Newronika and Soterix Medical). All of these
devices deliver constant current (Agnew and McCreery, 1987;
Bronstein et al., 2015). Stimulators differ for specific features, like
suitability for other stimulation protocols (e.g., tACS, tRNS), pro-
gramming capabilities, number of channels, size, weight, portabil-
ity, suitability for magnetic resonance imaging (MRI), and blinding
options. All certified tDCS-stimulators provide the basic features
required for tDCS. Thus, which stimulator to choose depends on
planned application (e.g., need for blinding protocols, desired
intensity level, number of electrodes, portability, wearability,
etc.). In any case, exactness of delivered current, as programmed,
is of crucial importance, and should be tested (e.g., by aid of an
oscilloscope), since, as discussed, minor deviances can result in
prominent alterations of experimental outcomes.
3. Transcranial alternating current stimulation (tACS)
tACS is a method of tES, which shares basic electrode montage
and low-intensity features with tDCS. However, in case of tACS a
sinusoidal current is applied to the scalp. This results in a few
important differences to tDCS that shall be discussed below.
3.1. Selecting tACS electrode placement
One of the main technical differences between tDCS and tACS is
the functional interpretation of the two or more electrodes
mounted on the scalp. In case of tDCS, these two electrodes are
referred to as anode and cathode because of the current crossing
into the body being positive and negative, respectively. For tACS
the concept of how to place the stimulation electrodes is quite dif-
ferent due to the applied alternating current. During one half cycle
of a tACS oscillation, one electrode will serve as anode and the
other one as cathode and current strength will increase and
decrease following a half sine wave. During the other half cycle,
the pattern will reverse and the former anode must now be consid-
ered the cathode and vice versa. Thus, on average, the membrane
potential is not affected and tACS is not intended to excite or inhi-
bit cortical activity monotonously. Instead, the main goal of tACS is
to influence brain oscillations (Herrmann et al., 2013). In contrastto tDCS, all cortical areas that receive stimulation, i.e. at least
two areas if two electrodes are used, are modulated in a similar
way.
3.2. Selecting experimental design
Compared to tDCS, tACS requires a different rationale for plan-
ning an experiment or intervention. At first, experimenters will
identify a cognitive or other process that is characterized by a
specific brain oscillation. Next, it has to be defined what parameter
of this brain oscillation is responsible or is thought to be responsi-
ble for which aspect of the respective process. It is possible to
enhance the amplitude of an electroencephalography (EEG) oscilla-
tion by applying tACS at the frequency of that oscillation (Zaehle
et al., 2010). Note that the changes that result from tACS may out-
last the duration of stimulation due to synaptic plasticity (Antal
and Paulus, 2013). In addition, the frequency of an EEG oscillation
can be modulated towards the frequency of tACS if the frequencies
of tACS are close to the intrinsic frequency of the EEG (Helfrich
et al., 2014a). Furthermore, the phase of the EEG could become
phase-locked to the alternating current of tACS. Thus, the phase
at a certain brain location can be modulated as well as the phase
coherence between multiple brain areas that are stimulated by dif-
ferent electrodes. It is important to be aware that the two sine
waves applied at the two tACS electrodes have a phase difference
of 180. Using a third electrode can then bring a cortical region
in-phase or out-of-phase with respect to the brain region stimu-
lated by one of the other electrodes (Polanía et al., 2012). Thus, if
the intent of stimulation were to stimulate two distant areas in
phase, dependent on the type of stimulator, it would be necessary
to split one of the channels and connect it to two electrodes, which
would then be in phase. In this case, a third electrode (the other
channel) will serve as the return electrode. Last but not least,
cross-frequency effects can be achieved. It has been shown that
stimulating the brain with 40 Hz tACS reduces oscillatory power
at 10 Hz representing cross-frequency coupling and supporting
the known antagonism between gamma and alpha oscillations
(Helfrich et al., 2014a).
3.3. Selecting stimulation parameters
The effect of increasing the intensity of tACS results in non-
linear excitability modulation of cortical tissue when 140 Hz tACS
is applied to the primary motor cortex (M1) and MEPs are
recorded in response to TMS pulses (Moliadze et al., 2012). Low
intensities of 0.4 mA result in a decrease of the amplitudes of
MEPs. Intermediate intensities of 0.6 and 0.8 mA showed no
significant effect, and a high amplitude of 1 mA resulted in eleva-
tion of the MEP amplitude. This was interpreted as inhibitory
neurons being more sensitive to 140 Hz tACS than excitatory
neurons that dominate the overall effect at high intensities. At
intermediate intensities excitation and inhibition cancel each
other out. Thus, non-linearities of the effects of different tACS
intensities should be taken into account.
Concerns have been raised about the applicability of placebo
protocols in tACS studies (Raco et al., 2014; Schutter and
Hortensius, 2010), as alternating current applied in the EEG fre-
quency range – dependent on electrode position and stimulation
intensity – can evoke phosphene perception during the entire
application of stimulation (Turi et al., 2013). Phosphenes during
tACS are most probably induced by retinal stimulation, as compu-
tational modeling studies of the path of the current flow suggest
(Kar and Krekelberg, 2012a). It was found that some portion of
the AC can reach the retina by passing through the eyes, due to
the current spread-effect, which is sufficiently strong to induce
phosphene perception in many subjects. Future experimental work
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protocols specifically for stimulation frequencies between the
alpha and gamma ranges.
3.4. Transcranial random noise stimulation (tRNS)
tRNS is also an alternating current stimulation technique, but at
a stimulation frequency continuously changing within a spectrum
of oscillations ranging from 0.1 Hz to 640 Hz. This technique is
more recent than the other types of tES, with very few studies
regarding mechanisms of action (Terney et al., 2008; Paulus,
2011). In general, it has been shown that tRNS, if applied over
the motor cortex, can increase MEP size. However, the effect of
stimulation is likely intensity-dependent (Moliadze et al., 2012).
Since tRNS is a repetitive stimulation, random and subthreshold,
it has been hypothesized that tRNS can induce mechanisms of tem-
poral summation of neural activity because the time constant of a
neuron is long enough to allow the sum of two or more stimuli in
close temporal sequence (Fertonani et al., 2011). Indeed, in a recent
pilot study the Na+ channel blocker carbamazepine trendwise
inhibited MEPs after tRNS application over the motor cortex
(Chaieb et al., 2015). Furthermore, the effects of tRNS can also be
explained in reference to the phenomenon of stochastic resonance
(Miniussi et al., 2013). Stochastic resonance refers to the phe-
nomenon that a signal that is too weak to exceed a threshold is
amplified by adding noise (McDonnell and Abbott, 2009). For
example, if random noise is added to the sub-threshold neural
oscillation in the brain, the sum of the two signals will exceed
the threshold at several timepoints, resulting in improved cogni-
tive performance (Cappelletti et al., 2015).4. Monitoring physiological effects of tES
4.1. Monitoring physiological effects of tES with TMS
TMS is one of the major tools used to monitor cortical excitabil-
ity alterations induced by tES. To explore the physiological effects
of tES, TMS is most frequently applied over the motor cortex.
Beyond motor cortex stimulation, TMS can be used to monitor
visual cortex excitability alterations via phosphene thresholds
(Antal et al., 2003; Kanai et al., 2008). TMS-EEG is suited to obtain
excitability alterations independent from cortical areas, which
deliver motor or sensory output (Pellicciari et al., 2013).
4.1.1. Monitoring of tES-induced motor cortex plasticity
The typical course of respective experiments is (a) determina-
tion of the motor cortex hot spot of the target muscle, and baseline
TMS intensity, (b) obtaining baseline excitability, (c) tES interven-
tion, and (d) obtaining intervention-induced excitability
alterations.
For (a), correct determination of the target muscle hot spot is
crucial to obtain reliable results. Neuronavigated coil placement
is helpful to guarantee constant coil position, and reduce variabil-
ity. Baseline MEP amplitudes before tES should be of medium size
to avoid ceiling or bottom effects. This is accomplished by a mean
MEP amplitude of about 1 mV, or a TMS intensity of 120% of resting
motor threshold (Nitsche and Paulus, 2000, 2001; Rossini et al.,
2015). The threshold-dependent method might result in somewhat
larger interindividual variability of MEP amplitudes. For reliable
baseline MEP amplitude determination (b), it is crucial that the tar-
get muscle is completely relaxed, and that alertness of the partic-
ipants is stable. Because of the intrinsic variability of MEP
amplitudes, a minimum of 20 MEPs should be obtained. Especially
the first MEPs are prone to artifacts caused by arousal or subopti-
mal coil position (Schmidt et al., 2009), thus these should beexcluded from further analysis, if contamination is suggested.
The same holds true for other MEP affected by muscle activity,
instable arousal or other sources of artifactual MEP. (c) During
intervention, TMS is rarely applied, since it was suspected that
TMS might affect tES-effects. This however seems not to be the
case, at least for tDCS (Nitsche et al., 2007b). If TMS is performed
during tES, baseline TMS measures should be performed with the
tES electrodes on the head to avoid differences of coil-brain dis-
tance, which would affect MEP size. Furthermore, flat electrodes
are preferable to guarantee constant coil position. If TMS protocols
are applied requiring muscle contraction for baseline determina-
tion of TMS parameters, these should be performed about 20 min
before intervention, because muscle contraction alters tDCS effects
(Thirugnanasambandam et al., 2011). For (d), post-intervention
TMS has been performed for up to over 24 h (Monte-Silva et al.,
2010, 2013a). Especially for these prolonged measures, coil and
EMG electrode position have to be guaranteed to be constant
throughout the experiment, e.g., by marking the respective posi-
tions, or use of neuronavigation. For protocols that require a con-
stant test pulse, or conditioning pulse intensity, post-tES
adjustment of TMS parameters is advantageous (Nitsche et al.,
2005). For monitoring neuroplastic effects, follow-up measures
should be conducted for a sufficiently long time, otherwise delayed
effects can be missed (Nitsche et al., 2004; Batsikadze et al., 2013).
Sufficiently long breaks between MEP blocks are required to pre-
vent subjects from becoming sleepy (e.g., 20 MEPs every 5 min
for 30 min, then every 30 min for up to 120 min after intervention).
In general, especially naïve subjects might have problems to
relax completely, and to stay in identical states of alertness
throughout the experiments. This enhances variability, and
reduces validity, of the outcome measures. This problem can be
circumvented by establishing a first session that is not included
in the terminal data analysis. In multiple session approaches, for
short-term plasticity effects (5 or 7 min stimulation) an inter-
session interval of one hour is sufficient (Nitsche et al., 2005;
Fricke et al., 2011). For long-term plasticity effects, an interval of
one week should avoid interferences, whereas a 24 h break is
insufficient (Monte-Silva et al., 2010, 2013a). In all cases, it is cru-
cial to describe in detail if tDCS experiments were implemented in
naïve subjects and if specific inclusion criteria were implemented
(i.e., responders vs. nonresponders, subjects with MEP > than a cer-
tain value, subjects with/without phosphenes, etc.). A complete
description of the strategy utilized for subject selection is crucial
to allow replicability of results and to allow meaningful compar-
isons across studies.
Many of the suggestions made for motor cortex TMS protocols
are also relevant for visual cortex TMS and TMS-EEG studies, thus
for the sake of brevity we avoid an extensive discussion.
4.2. Monitoring physiological effects of tES with
electroencephalography (EEG) and event-related potentials (ERPs)
EEG is one of many methods available to study the state and
function of the human brain. Although EEG lacks the spatial reso-
lution of other techniques, such as functional MRI (fMRI), it pos-
sesses several qualities that can provide unique insight on how
tES changes brain activity. The clear utility of integrating EEG with
tES lies in the fact that EEG is a measure of electrical activity,
directly reflecting the electric state of neurons. Specifically, the
scalp-recorded EEG signal measures voltage fluctuations resulting
from ionic current flow (Kappenman and Luck, 2011) –current flow
that can be directly modulated with tES. Moreover, the excellent
temporal resolution of EEG offers the potential to identify specific
brain responses to tES and how they evolve throughout stimula-
tion, elucidating changes in processing over time within an area
or across circuits (Miniussi et al., 2012; Bortoletto et al., 2014).
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necessary to successfully combine EEG recordings with tES based
on currently available evidence in the field. It should be noted,
however, that this is a relatively new area of investigation, and
there are many aspects of EEG-tES combination that have yet to
be systematically investigated. For a discussion of how tES-EEG
can inform about products of excitability changes induced by tES,
see Miniussi et al., 2012.
4.2.1. Selecting an approach
Experiments that combine tES and EEG can be divided into two
methodological approaches: the offline or sequential method,
which evaluates the short- and long-term after-effects of brain
stimulation, and the online or simultaneous/concurrent method,
which evaluates the immediate and ongoing changes that occur
during stimulation. Only the online approach, which involves
recording EEG concurrently with brain stimulation, can be defined
as tES-EEG coregistration. These two approaches provide different
information about mechanisms and create unique technical chal-
lenges. Therefore, it is important to clearly specify which method
was used when describing an experiment. Additionally, it is also
very important to explicitly describe the temporal relation
between tES and the EEG recording. In the case of sequential
tES–EEG, it is important to report how much time separated the
tES and EEG recording sessions. For concurrent tES–EEG, it should
be specified how much of the tES overlapped with the EEG record-
ing. This information is relevant to the interpretation of results and
has significant implications for potential replication attempts.
4.2.2. Integrating tES and EEG electrodes
There are a number of challenges that exist in integrating tES
with EEG recordings. At present, a few dedicated commercial sys-
tems are available that are specifically designed to integrate tES
with EEG (Schestatsky et al., 2013). In the following section, we
will primarily consider how to integrate tES with EEG in the event
that such a combined system is not used.
The first challenge we face in integrating tES with EEG is how to
interface the tES electrodes with the EEG electrodes without caus-
ing interference or bridging between electrode sites. The first and
simplest solution is to place the tES electrodes underneath the
EEG electrode cap, making sure that the EEG electrodes are not
directly on top of or close to the tES electrodes. However, this
approach does not allow access to the tES electrodes during stim-
ulation, making it difficult to fix issues that may arise throughout
the session, such as drifting of the electrodes, evaporation of sal-
ine/drying of electrode gel, or increases in impedance at the elec-
trode sites. This approach is also subject to potential bridging
between tES and nearby EEG electrode locations. An alternative
solution is to create specific ‘‘windows” in the electrode cap (e.g.,
cut outs) for placement of the tES electrodes. This approach would
permit direct access to the stimulation area; however, there are a
limited number of cuts that can be performed on the caps, and
removing sections of the electrode cap may alter the location of
remaining electrode sites by disrupting the overall fit of the cap.
Moreover, although bridging is less likely with this arrangement
than in the case of placing tES electrodes underneath the electrode
cap, gel/saline can still spread over the tES electrode and cause
bridging with adjacent EEG electrodes. To reduce bridging, it is
possible to use self-adhesive tape on the cap over the border of
the cuts between the cap and the skin to minimize the spreading
of the conductive medium. More recently, it has become possible
to deliver tES by means of small electrodes that are similar in size
to EEG electrodes. This approach, called high definition tES (Datta
et al., 2009), can be easily integrated with EEG by mounting both
EEG and tES electrodes in the same cap. This approach minimizesmany of the issues described above, providing continued access
to the tES electrodes throughout the session, and minimizing the
potential for electrical bridging between adjacent electrode loca-
tions (although care should still be used to ensure that gel does
not spread to adjacent sites).4.2.3. Recording EEG during tES
Concurrent tES-EEG recordings face additional challenges over
the sequential method. Importantly, EEG involves recording elec-
trical activity on the surface of the head, and tES involves the appli-
cation of electrical current on the surface of the head. Therefore,
these two techniques can interfere with each other in important
ways. This is true even in the case of tDCS, which involves applica-
tion of a DC current outside of the typical AC range examined in
EEG/ERP experiments. One issue faced in simultaneous tES-EEG
recordings is that the tES is orders of magnitude stronger than
the signals recorded with EEG, resulting in saturation of an EEG
recording amplifier that does not have a sufficient input range. In
some cases, saturation may appear only in the EEG channels
located nearby to the tDCS electrodes (Accornero et al., 2014).
Noise can also be introduced by the tES system during the EEG
recording. Specifically, the tES system contains an electronic circuit
that can be the source of external noise, and this noise can be
recorded in the EEG. This noise can be minimized or eliminated
by using a stimulator that has adequate isolation.
It is relatively easy to determine whether these external sources
of noise described above may impact EEG recordings by testing
with a phantom head (see below). Therefore, it is recommended
that individuals interested in recording EEG during tES follow a
set of simple procedures to evaluate their tES equipment/stimula-
tion parameters in the context of the EEG system. These proce-
dures simply involve recording EEG both without tES and during
application of tES using a phantom head, eliminating the influence
of biological artifacts. The EEG recordings can then be compared
between the session with tES and the session without tES to iden-
tify any unwanted artifacts or induced frequencies present in the
recorded signals with simultaneous tES. One easy phantom head
is to use a small melon (e.g., a cantaloupe melon, of about the
dimension of a small head), that can be stimulated with tES, allow-
ing the recording of any artifacts induced by the tES device
(Veniero et al., 2014). Alternatively, a fake head can be created
by connecting three resistors together to form a triangle, and con-
necting each corner of the triangle to wires leading to the active,
ground, and reference inputs in the EEG system (Luck, 2014). How-
ever, it is important to note that tES may also induce biological
artifacts, and therefore not all artifacts will appear in testing with
a phantom head. It is therefore also recommended that the same
procedures be completed with a human research participant to
fully examine the potential for artifacts.
In some cases, filtering the EEG with a 0.5 to 70 Hz band pass
filter may effectively attenuate artifacts related to tDCS
(Accornero et al., 2014). In the case of residual artifacts, it is recom-
mended to follow the general guidelines provided by the Society
for Psychophysiological Research for artifact rejection/correction
procedures for EEG/ERP studies (Keil et al., 2014). In addition, all
artifacts should be sufficiently described in publications, along
with any procedures used to remove or correct for the artifacts.
There are no specific acquisition parameters in terms of sampling
rate, impedance, or online filtering outside of the general recom-
mendations for EEG recordings (Keil et al., 2014; Luck, 2014). The
recording of EEG is traditionally performed with electrodes made
of tin, silver, silver-chloride, gold or more recently sintered
silver/silver-chloride electrodes. The sintered electrodes seem to
be ideal in this respect because they are less sensible to polariza-
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mal low-frequency noise (Tallgren et al., 2005).
The application of tACS or tRNS is even more challenging
because these modalities of stimulation induce an oscillation that
impacts the whole recorded signal. Nevertheless, thanks to the
development of dedicated algorithms it might be possible to
remove the signal from tACS-induced artifacts in cases in which
the tACS frequency does not overlap with frequencies examined
in the EEG/ERP signals (Helfrich et al., 2014b). Therefore, in the
case of tACS, an additional algorithm is likely necessary to remove
the tES-induced signal without altering the cortical signal,
although it should be noted that the effectiveness of these algo-
rithms at removing the artifact signals has not been systematically
evaluated yet in these domains.
4.3. Monitoring physiological effects of tES with magnetic resonance
imaging (MRI) and magnetic resonance spectroscopy (MRS)
Integration of tES with human magnetic resonance (MR) pro-
vides a novel avenue for investigating the neural mechanisms
underlying tES. To date, the majority of research integrating tES
with MR has focused on integration of tDCS. This section will dis-
cuss how tDCS has been integrated with fMRI, both in terms of
Blood Oxygen Level Dependent (BOLD) fMRI (Baudewig et al.,
2001) and Arterial Spin Labeling (ASL; Zheng et al., 2011; Stagg
et al., 2013); as well as proton and non-proton MR Spectroscopy
(MRS; Rango et al., 2008; Stagg et al., 2009; Binkofski et al.,
2011; Clark et al., 2011; Stagg and Nitsche, 2011; techniques here-
after collectively referred to as MR in this section). tDCS and MR
have to date been combined in a number of ways depending on
the nature of the question posed, from the technically most simple
where fMRI is used to guide subsequent tDCS application (Woods
et al., 2014) to approaches where tDCS and MR are performed in
the same session. tDCS can be applied in the bore of the magnet,
with the option of acquiring data during stimulation (concurrent
acquisition) or subjects can be removed from the scanner, tDCS
applied, and then replaced in the scanner (sequential acquisition).
4.3.1. Integration of tDCS with MR
Prior to the advent of MR compatible tDCS systems, studies
were limited to sequential acquisition. This presents logistical
and analytical issues for BOLD fMRI and MRS data, although these
issues can be at least partially overcome. However, with the advent
of MR-compatible tDCS systems, both sequential and concurrent
acquisitions are possible. Thus, participants can undergo baseline
scans prior to stimulation, simultaneous acquisition of data during
stimulation, and/or post-stimulation scanning while remaining in
the same position throughout the scan. This has obvious advan-
tages for studies where the reproducibility of voxel placement, or
high-resolution fMRI is required. However, integration of the tDCS
device into an MRI system is not without complications, and a
number of aspects should be considered. Importantly, MR-
compatible systems should have high-ohmic resistors in the stim-
ulating circuit (commonly 10 kOhm) to prevent the induction of
eddy currents within the stimulating leads.
When tDCS is integrated with MR, subject safety standards for
both MR and tDCS should be adhered to (e.g., no metal on or in
the head, no implants susceptible to electrical current or magnetic
fields, etc.). In order to acquire good data, the localization of elec-
trodes, careful preparation/placement of electrodes, stable fixation
of the electrodes to the head, etc. remain critical considerations for
tDCS combined with MR, as they are with tDCS alone (see section
on electrodes above for detailed description of these
considerations).However, some specific issues need to be addressed when using
tDCS in the MR bore. Firstly, biocarbon electrodes should be
attached to the participant using thick electrical conductance paste
(e.g., Ten20 paste), rather than saline soaked sponges or low vis-
cosity electrode gel. As sponges begin to dry after 20 min, but
scanner sessions commonly last one or more hours in duration,
conductance paste avoids premature drying of electrode sponges
when using saline. Drying of the sponge leads to an increase in
resistance and runs the risk of pain and skin burning to the subject.
Furthermore, electrode paste, rather than electrode gel, allows
preparation of a thick coating (P3 mm) of paste to provide suffi-
cient distance between biocarbon electrodes and scalp, ensuring
that stimulation is delivered evenly across the electrode. Paste
should be applied directly to the biocarbon electrode and thickness
of paste prep kept consistent, preferably measured for precision.
The adhesive quality of the paste assists in affixing the electrode
to the targeted location/scalp, but also requires additional elastic
straps for fully secure placement.
Care should be taken at this stage to ensure that the electrodes
do not move, and electrodes can be marked with oil-capsules so
their position can be checked on the resulting images. It is vital
to ensure that electrodes are not in contact with the head coil, or
headphones, to prevent electrode displacement and unexpected
interactions between the stimulator and the scanner.
Additionally, tDCS within the MR bore requires careful insertion
of specially designed MRI-compatible (non-ferrous or appropri-
ately shielded) tDCS cables and electrodes through the magnet
suite waveguide and into the magnet bore. These should run par-
allel to the bore, without loops and away from the subject to pre-
vent the risk of eddy current induction and potential RF burns.
4.3.2. Considerations for concurrent MR acquisition
Introduction of an electrical current into the scanner’s magnetic
field results in further warping of the magnetic field (i.e., field arti-
fact). This artifact is of critical concern for BOLD fMRI protocols, as
it may result in false positive patterns in BOLD signal. The impact
of field artifacts may also alter MRS and ASL-based sequences as
well. The magnitude and nature of any artifacts are likely to
depend on the exact experimental setup and therefore will in all
probability vary from center to center. One study demonstrated
evidence of BOLD signal within brains of two cadavers during a
concurrent tDCS and fMRI protocol (Antal et al., 2014b). Another
study demonstrated visual evidence of change in echo-planar
imaging (EPI) field maps that was limited to the scalp and cortical
tissue near to the electrode site (Holland et al., 2011). To date, very
few studies have provided data on change in the magnetic field in
relation to concurrent tDCS-MR. These contrasting cases demon-
strate the need for careful consideration of concurrent data and
acquisition of appropriate field map data to allay concerns over
false positive functional results from perturbation of the magnetic
field. Specifically, brief acquisition of EPI field maps with and with-
out stimulation within participants (1 min per field map) should
become standard procedure for concurrent data, as absence of this
data undermines interpretation of data.
4.3.3. Other considerations for tDCS integrated with MR
At present, most published studies using combined tDCS and
MRI/MRS methods have used limited sample sizes (average sample
size of all tDCS-MR papers published between 2001 and
2014 = 10.8 ± 5.7). While these sample sizes were also common
in early MR studies over a decade ago, sample sizes of this scope
have proven insufficient in most modern MR studies, leading to
underpowered and difficult to replicate findings. Future tDCS-MR
studies should strive to adhere to appropriate MR and tDCS specific
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of data and potential for future replication.5. Monitoring functional effects of tES
5.1. Monitoring functional effects of tES in healthy subjects
An increasing number of studies have applied tDCS to modulate
neuroplasticity in the motor system or in other cortical networks of
interest. Since memory formation and retention are processes that
cannot be measured directly, their state is typically inferred indi-
rectly using electrophysiological markers or measures of behav-
ioral performance that change in response to practice and reflect
increased efficacy of task performance. When using behavioral out-
come measurements, the choice of task and the associated perfor-
mance metric are critical for reliably detecting tDCS effects.
Important parameters include task complexity, type of task (e.g.,
tDCS can have antagonistic effects in noisy and non-noisy tasks;
Antal et al., 2004b) and the amount of training, which must be
appropriate for the skill level of the participant otherwise facilita-
tory tDCS effects might be masked by ceiling effects in perfor-
mance measures (Furuya et al., 2014a). Moreover, the brain’s
ability to undergo neuroplastic changes differs across populations.
Applying tDCS with the goal of up-regulating learning tends to
induce smaller effects in young adults who exhibit a near-
optimal level of neuroplasticity than, for example, in elderly
(Zimerman et al., 2013). Similarly, using 1 mA tDCS under the cath-
ode electrode to down-regulate plasticity seems to be most effec-
tive in individuals that exhibit maladaptive plasticity that is too
high, as it is the case with dystonia (Furuya et al., 2014b). Note,
however, that pathology might also change a patient’s responsive-
ness to tDCS. For example, multiple sclerosis patients whose motor
learning ability is impaired did not benefit from tDCS during motor
training, even though the stimulation protocol is suitable to
enhance plasticity when applied in healthy populations (Meesen
et al., 2014).
Modulatory effects of tDCS on neuroplasticity are small com-
pared to the large inter-individual variability in learning typical
in humans. For example, consider a common design where tDCS
is applied during a single practice session to boost learning in com-
parison to a sham control group. Given that subject samples are
often of moderate size, the observed behavioral effects might be
too small to differ significantly from sham stimulation. However,
there is evidence that modulatory effects accumulate when tDCS
is applied during multiple, consecutive sessions (Reis et al., 2009;
Alonzo et al., 2012; Waters-Metenier et al., 2014), and that tDCS
effects might require a consolidation period to be fully expressed
(Reis et al., 2009, 2013). It was initially thought that tDCS applied
at rest prior to practice can prime the cortex for learning, and that
tDCS applied after practice can facilitate consolidation. However,
experimental evidence that supports this idea is sparse. Notably,
when tDCS is applied immediately before or after motor practice,
effects are rarely additive because the interventions might interact
according to homeostatic principles (i.e., facilitating protocols
might suddenly suppress plasticity and vice versa; Müller-
Dahlhaus and Ziemann, 2014) thus leading to counter-intuitive
results. On the other hand, there is mounting evidence that apply-
ing tDCS during practice triggers effects that outlast the stimula-
tion period and facilitate neuroplasticity and long-term memory
formation. (Fritsch et al., 2010; Reis et al., 2013; Saucedo
Marquez et al., 2013).
Functional effects of tDCS are also monitored via cognitive
tasks. Indeed, tDCS has been added to the technical arsenal of cog-
nitive neuroscientists and has revealed important evidence on both
the relationship between brain and behavior as well as on its effi-cacy as a cognitive neuroenhancement tool (Kuo and Nitsche,
2012; Miniussi et al., 2013). However, several aspects should be
considered when establishing cognitive assessment protocols for
testing technical safety or for investigating its role as a cognitive
intervention method. First, the effect of tDCS on cognition has been
frequently assessed by classical neuropsychological tasks that are
not necessarily sensitive to the subtle changes it induces. Secondly,
different tests are often used by different authors making compar-
isons across studies difficult. Importantly, standard tDCS protocols
have only a moderate level of spatial specificity; for example, a
positive effect on working memory is observed when stimulating
DLPFC, but not M1 (Fregni et al., 2005). However, the spatial reso-
lution of tDCS is too low to precisely stimulate functional subdivi-
sions of a cortical area so that different cognitive functions have
been modulated even though similar tDCS protocols were applied
(i.e., similar target areas, electrode size, stimulation parameters).
This highlights that caution is required when interpreting cognitive
findings. Also, little is known about the additive effects of tDCS and
cognitive tasks (Andrews et al., 2011; Miniussi et al., 2013;
Carvalho et al., 2014). Thus, further studies are needed to explicitly
compare the effects of cognitive assessment during and after stim-
ulation. Finally, cognitive tDCS protocols should consider the pos-
sibility that differences in polarity, current intensity, electrode
size, time of stimulation and volunteer group lead to different
modulatory effects (Boggio et al., 2006; Jacobson et al., 2012;
Kuo and Nitsche, 2012; Carvalho et al., 2014). For example, a pos-
itive effect on working memory in healthy young participants can
be obtained with 1 mA tDCS (Fregni et al., 2005) whereas the same
effect is only observed with 2 mA stimulation in patients with
Parkinson’s disease (Boggio et al., 2006). Another example is the
differential effect of tDCS on risk behavior when applied in healthy
young or elderly subjects. Using the same methodology Fecteau
et al. (2007) showed that tDCS applied over DLPFC decreased risk
behavior in younger subjects while Boggio et al. (2011) showed
the opposite effect in elderly.
It has been shown that tACS is an appropriate tool to modulate a
wide range of cognitive functions (Antal and Paulus, 2013;
Herrmann et al., 2013; Fröhlich et al., 2015) including perception
(Feurra et al., 2011a,b), attention (Laczó et al., 2012), working
memory (Jaušovec and Jaušovec, 2014), declarative memories
(Marshall et al., 2006), fluid intelligence (Santarnecchi et al.,
2013), decision making (Sela et al., 2012) and self-awareness when
dreaming (Voss et al., 2014). Most previous studies applied tACS
with the goal of entraining intrinsic brain oscillations that are
essential for successfully performing a behavioural task. The basic
idea is that applying alternating currents simultaneously to a large
number of neurons modulates oscillatory network activity in a fre-
quency specific manner (Frohlich and McCormick, 2010; Ali et al.,
2013) even if the externally applied current is small (Reato et al.,
2013).
In order to apply this principle within an experimental context,
efficacy of tACS is best when tailored to the specific oscillatory sig-
nature observed within the targeted brain area and for the investi-
gated behavioural task. tACS entrainment has been demonstrated
for a large variety of tasks (Antal and Paulus, 2013; Herrmann
et al., 2013; Fröhlich et al., 2015), however, the observed behav-
ioral effects were largest when appropriate frequency bands were
stimulated while stimulation with control frequency had no or
minor effects (Pogosyan et al., 2009; Joundi et al., 2012;
Santarnecchi et al., 2013; Lustenberger et al., 2015). Most of these
previous studies applied tACS for ‘‘typical” frequency bands reflect-
ing a population average for a specific task. However the efficacy of
tACS might be further increased by considering inter-individual
differences of intrinsic oscillations (e.g. the frequency peak of
alpha-oscillation can vary between 8 and 14 Hz), i.e. by matching
the tACS frequency to individual peak frequencies over the cortical
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frequency, even if small, might induce other effects than intended
(e.g., by slightly shifting alpha frequency; Cecere et al., 2014) or
reduce the efficacy of tACS entrainment (Ali et al., 2013). Neverthe-
less, even in the same subject, individual intrinsic oscillatory activ-
ity slightly varies during the course of a given task or exercise (e.g.
due to attentional load, learning effect, emotional and motivational
changes, etc) and might decrease the effectivity of the stimulation
even when the individual peak frequency is applied. Furthermore,
when tailoring the tACS stimulation frequency to a specific task it
is important to keep in mind that entrainment effects might not be
restricted to the stimulation frequency per se, but might also affect
neural activity within other frequency bands, which are influenced
via cross-frequency interactions (Helfrich et al., 2014b) or are
higher harmonics of the stimulation frequency (Miniussi et al.,
2013; Reato et al., 2013).
Most higher-order cognitive functions are associated with long-
range communication between different brain regions that depend
not only on oscillation frequency, but also the phase coupling
between the two neuronal populations. Modulating the phase rela-
tionship for a given frequency band has been shown to modulate
cognitive function (Polanía et al., 2012; Helfrich et al., 2014b).
Thus, consideration of the phase-relationship between different
cortical areas is important, particularly when using a two-
electrode setup with both electrodes mounted over the cortex,
since this setup can only provide out-of-phase (180) stimulation.
By contrast, using a multi-electrode montage (three or more elec-
trodes) provides better experimental control over the phase rela-
tionship between remote yet interacting oscillating neuronal
populations. Finally, it is well known that tACS at frequencies
below 30 Hz induces visual phosphenes in most participants, how-
ever dependent on electrode position and stimulation intensity
(Kanai et al., 2008). Phosphenes emerge most likely because a
substantial part of the applied current is shunted via the skin to
the eyes where it either affects retinal cells or the optical nerve
(Kar and Krekelberg, 2012b). In order to exclude that functional
effects are driven by supra- or subthreshold stimulation of the
retina/optical nerve rather than by modulating neural activity of
a specific cortical area, it is strongly recommended to include a
control experiment where both electrodes are placed over control
sites.
5.2. Monitoring functional effects of tES in patients
tES – particularly tDCS – has been increasingly investigated as a
treatment option for neurological and psychiatric disorders in the
past years. The interest in using tES for treatment purposes relies
on several compelling characteristics for clinical use, such as
safety, tolerability, ease of use, cost and portability. As discussed
in 2.6, currently applied protocols are safe and well tolerated by
subjects. For instance, in a recent literature review, data from all
tDCS clinical studies performed from 1998 to August 2010 were
collected (Brunoni et al., 2011a). Of 209 studies (172 articles,
encompassing almost 4000 subjects), similar rates in frequency
of adverse effects in the active vs. sham arms were observed. The
most common adverse effects were headache, itching, burning, dis-
comfort and tingling, occurring in 10–40% of patients regardless of
treatment group.
Some aspects have to be taken into account when applying tES
in clinical populations, which are in many instances related to
pathologically altered disease-related physiology. The common
rationale for tES application to reduce clinical symptoms is to ‘‘nor-
malize” pathological brain activity and excitability. Thus, in most
cases, electrodes are positioned over the area associated with the
pathology under study – for instance, in depression electrodes
are placed over the dorsolateral prefrontal cortex, an area in whichactivity is pathologically altered (Koenigs and Grafman, 2009). As
discussed, although not necessarily valid in all scenarios, the rule
of thumb of anode promoting increased cortical excitability and
cathode inducing the opposite effects is commonly employed in
clinical trials. For example, in one schizophrenia trial the cathode
was placed over the left temporoparietal area, an area in which
activity is supposedly increased in some schizophrenia patients
with positive symptoms (Brunelin et al., 2012). However, indirect
modulation of target areas via connected cortices has also been
performed, as in motor cortex stimulation for pain treatment
(Bolognini et al., 2015).
For the specific stimulation protocols applied, it should be taken
into consideration that tDCS as a neuromodulatory intervention
has effects that are brain state-dependent. Thus, similar to other
plasticity-inducing stimulation protocols, stimulation might have
reduced or even inverted effects in specific clinical populations
(Fregni et al., 2006; Player et al., 2014). Concomitant pharmacolog-
ical treatment can furthermore alter the effects of tDCS, an impor-
tant consideration for all tDCS studies. For instance, it was shown
in depression trials that benzodiazepines decrease tDCS clinical
efficacy whereas antidepressant drugs increase it (Brunoni et al.,
2013a,b). Furthermore, neurophysiological studies in healthy
humans (for a review, see Stagg and Nitsche, 2011) showed an
influence of benzodiazepines, antipsychotics, lithium, anticonvul-
sants and serotoninergic antidepressants on tDCS effects. Since
these studies were conducted in healthy humans, and the outcome
parameters were surrogate markers, the degree of transferability of
these data to clinical populations is not clear at present. Thus, in
most cases, the recruitment of drug-free samples would be the
optimal approach to avoid confounding effects of pharmacother-
apy on tDCS effects. However, this is not always feasible due to eth-
ical and pragmatic reasons. In such cases, pharmacotherapy should
remain stable for at least 4–6 weeks to minimize the confounding
effects and concomitant pharmacotherapy should be reported in
trial results. However, since tDCS and pharmacotherapy have been
shown to have synergistic effects in specific cases, e.g., serotonin
reuptake inhibitors combined with tDCS in depression (Brunoni
et al., 2013b), systematic variation of pharmacotherapy as part of
the intervention protocol can also be an option.
Another factor that can influence tDCS effects is ‘‘dose”. In fact,
although there is no standard definition of how to measure the
‘‘dose” of tDCS delivered in a clinical study, factors that influence
the amount of current injected are the size of electrodes, the elec-
tric current intensity, the duration of the tDCS session and the total
number of sessions. Some studies have shown greater cognitive
improvement with higher current doses (Iyer et al., 2005b;
Boggio et al., 2006). The interval between sessions (e.g., every other
day, once daily, twice daily etc.) might also influence the clinical
effects. Furthermore, timing of stimulation in relation to task per-
formance, e.g., when rehabilitation should be fostered, is presumed
to have an impact on the results. Similar to studies in healthy
humans (see above), conductance of tES during task performance
might be superior to separated interventions, especially if (re-)
learning procedures are involved (Nair et al., 2011; Bajbouj and
Padberg, 2014).
For study design, two main types of study are used to evaluate
the functional effects of tES in patients. In the first one, the func-
tional effects of tES are evaluated immediately after or even during
(‘‘online”) stimulation. These studies commonly use a within-
subjects (cross-over) design in which participants are randomized
to receive the active(s) and the sham sessions with a time interval
(ranging from one day to one week) between them to avoid carry-
over effects. These study outcomes are usually surrogate, i.e., they
compare the effects of active and sham tDCS on a biological marker
or an endophenotype (e.g., changes in cortical excitability (Hasan
et al., 2012), performance in a neuropsychological test
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mechanisms of action of tDCS, or the pathophysiology of the dis-
ease. In the second type, typically the effects of repeated tDCS ses-
sions, applied once daily or more frequently for several days, are
evaluated. The primary outcomes are usually clinical (although
surrogate biomarkers are evaluated as well; Brunoni et al., 2012)
and the research question aims to explore whether tDCS has a ther-
apeutic effect for a neuropsychiatric condition. There are many
potential study designs principally suited for this type of study:
open-label trials (without a sham control, due to tricky interpreta-
tion of results only suggested for first exploratory data acquisition;
Brunoni et al., 2011b) or double-blinded sham-controlled trials,
such as two-arm trials (comparing active to sham tES (Brunelin
et al., 2012) or, in a ‘‘double-dummy” approach, comparing active
tDCS + placebo pill vs. sham tDCS + pharmacotherapy), triple-arm
trial (comparing tDCS, pharmacotherapy or placebo; or two types
of active tDCS and placebo; Boggio et al., 2008) and factorial
designs (placebo, only tDCS, only pharmacotherapy and combined
treatment; Brunoni et al., 2013b) The latter design is particularly
interesting for testing two interventions simultaneously, combined
and also one intervention against another. However, although
comprehensive, a factorial approach requires more resources and
a larger sample size. In any case, given the proneness of many dis-
eases for placebo effects, reliable double blinding in case of sham-
controlled designs, as outlined above, is of utmost importance in
these studies.
Design and sample size considerations in tDCS clinical studies
further depends on the methodological purpose of the study (supe-
riority trials vs. non-inferiority ones). Especially non-inferiority
tDCS trials require cautious sample-size determination, as negative
findings (no difference between tDCS and the comparator) due to
underpowering in non-inferiority trials could be easily
misinterpreted.
6. tDCS/tACS/tRNS in animal preparations
Animal studies spanning decades have tried to elucidate the
mechanisms by which electric currents can affect neurons. This
section summarizes recent work with a special focus on low-
intensity stimulation using DC (Direct Current), AC (Biphasic Sinu-
soid), and RN (Noise) waveforms, highlighting findings from
in vitro and in vivo studies.
6.1. DC-, AC-, RN-induced membrane polarization
Stimulation across the head with a specific waveform of current
produces an electric field across neurons with a comparable wave-
form. When stimulation is low-intensity (‘‘sub-threshold”), then
weak changes in membrane polarization are produced that, to a
first approximation, simply track the same waveform.
DC stimulation (as in tDCS) produces a tonic shift in the mem-
brane potentials of neurons (Chan et al., 1988; Bikson et al., 2004).
Changes in membrane potential will influence neuronal excitabil-
ity in a stimulation polarity-specific manner. An anode at the cor-
tical surface is expected to produce inward flow (relative to the
cortical surface), producing depolarization of the pyramidal neuron
soma, which may increase excitability (Radman et al., 2009). Con-
versely, a surface cathode will produce soma hyper-polarization,
decreasing excitability. For tDCS-relevant intensities, the magni-
tude of this polarization is low. Importantly, dendrites and axons
are also polarized, and the extent and direction of this polarization
will influence net changes in excitability (Rahman et al., 2013).
Though this concept is well established and supported by experi-
mental studies, it is often misapplied in human tDCS research at
macro-, meso-, and micro-scopic levels. At the macro-level, it
may be disingenuous to discuss ‘‘anodal tDCS” or ‘‘cathodal tDCS”without acknowledging the presence of a return electrode. Physics
dictate that the amount of current crossing in and out of the brain
is eqal. At the meso-scopic level, the folding of the cortex produces
inversions of current flow even locally under the electrode,
including inversions across single gyri (Datta et al., 2009); to
assume that the current flow into the cortex is unidirectional
under any electrode is misleading. Finally, at the micro-scopic
level is it incorrect to refer to anodal stimulation as simply
‘‘depolarizing” when in fact there is an equal amount of
compartment de- and hyper-polarized under any condition
(Bikson et al., 2004; Rahman et al., 2013). The fact that these
biophysical phenomena are not convenient for simplistic interpre-
tation and design of tDCS, does not make them less true.
AC stimulation (as in tACS) also modulates the membrane
potential of neurons at the frequency of the applied stimulation
(Deans et al., 2007). Thus, differently from DC stimulation, AC cur-
rents fluctuate in time, creating a temporal succession of depolar-
ization and hyperpolarization in neuronal compartments (Radman
et al., 2007). The filtering properties of the membrane (Bikson
et al., 2004) also make the induced polarization frequency specific,
with high frequencies less effective in modulating excitability
(Deans et al., 2007). This last fact along with the delay in polariza-
tion produced during tACS is often ignored in trial interpretation or
design. For example, research on optimal or customized frequency
should consider that under fixed intensity, higher frequency will be
less effective in producing membrane polarization (Reato et al.,
2013). Studies interested in phase must consider the timing delay
between maximum polarization and stimulation phase, which will
also be stimulation frequency specific (Radman et al., 2007).
With RN stimulation (as in tRNS), the membrane potential is
again expected to follow the waveform of the stimulation with
neural compartment specific changes in sensitivity and polarity,
and filtering of high frequency signals. If the RNS is biphasic, then
the membranes will fluctuate between depolarization and hyper-
polarization. Stochastic resonance (Moss et al., 2004) has also been
suggested as a possible mechanism to mediate the effects of tRNS.6.2. What can we learn from in vitro experiments?
Finite-element models of transcranial stimulation provide esti-
mates of the electric fields induced in the brain when transcranial
stimulation is applied with conventional current intensities and
electrode montage. A current of 1 mA, using a 5  5 cm2 electrode
can induce an electric field with a maximum peak of less than 1 V/
m (Datta et al., 2009). Ultimately, whether a stimulation protocol
will be successful in modulating brain functions depends on how
electric fields of this magnitude are effective in polarizing neurons
and modulate their activity. In vitro studies have been crucial for
understanding how weak electric fields affect neurons (Jefferys,
1981; Chan et al., 1988).
Obviously, the general limitation of in vitro studies is the diffi-
culty to translate directly the results to humans. Brain slices have
reduced neuronal populations with no inputs from other areas,
reduced connectivity (due to the slicing procedure), artificial cere-
brospinal fluid (CSF), and usually, cannot show spontaneous tran-
sitions to different dynamical states. However, there are specific
advantages of using in vitro preparations depending on the scien-
tific question being asked and in providing precise control of the
electric field and slice activity. First, the effects of electric fields
can be studied at the sub-cellular, cellular and population level.
Second, the stimulation can be controlled in a very precise manner.
Third, pharmacological manipulations can easily be used to help
elucidating the effects of electric fields, especially the synaptic
modifications that may underlie the long-term effects of the
stimulation.
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of Ag-Ag/Cl, to create a spatially uniform electric field (same ampli-
tude in every location between the wires; Jefferys, 1981; Chan and
Nicholson, 1986; Bikson et al., 2004b; Radman et al., 2007b;
Frohlich and McCormick, 2010; Reato et al., 2010; Rahman et al.,
2013b). The use of long wires ensures a uniform electrode field.
The use of Ag-Ag/Cl material is intended to minimize electrode
polarization providing a consistent electric field. This also mini-
mizes electrochemical products, but actually tissue may be pro-
tected simply by putting the electrodes in the bath at a distance
from the tissue. This configuration allows the experimenter to
study the effects of currents on brain slices placed between the
wires with a great control of the electric field magnitude, direction
and waveform. Conventional electrodes can then be used to
measure the electrical activity of single neurons or the average
population. Changes in membrane potential, firing rate or syn-
chrony in single neurons, evoked population responses or power
modulation in pharmacologically induced active network are typi-
cal measures to estimate the effects of electrical stimulation on
neuronal activity.
In most animal studies, the electric fields used are significantly
larger than those produced in the brain during tDCS, tACS, and
tRNS. This may facilitate the discovery of phenomena and have
produced valued predictions and insight on mechanisms
(Jefferys, 1981; Chan and Nicholson, 1986; Bikson et al., 2004;
Rahman et al., 2013; Reato et al., 2015). Only few in vitro studies
have used electric fields comparable in magnitude to the ones
induced by transcranial electrical stimulation in humans (<1 V/m).
AC fields as low as 0.2 V/m have been shown to affect gamma
oscillations in vitro (Reato et al., 2010). A previous study, using a
similar preparation also reported a similar minimum value for
measuring effects on gamma oscillations (0.25 V/m; Deans et al.,
2007b). For entrainment of slow waves, the minimum electric field
reported is 0.5 V/m (Frohlich and McCormick, 2010), while for
epileptic-like activity, 0.3 V/m (Francis et al., 2003). Electric fields
on the order of 1 V/m have also been shown to entrain neuronal fir-
ing during slowwaves in vivo (Ozen et al., 2010). DC fields as low as
0.75 V/m can also modulate evoked responses (Fritsch et al., 2010).
In almost all of these studies, low amplitude electric fields were
able to modulate active neuronal networks. Indeed, it seems that
the activity of the network can amplify the effects of the stimula-
tion by virtue of the positive feedback of synaptically connected
neurons experiencing similar polarizations (Reato et al., 2013).
Results from in vitro studies also support the idea that the effects
of weak electrical stimulation may depend on the dynamical state
of the neuronal network of interest. This dynamics is often set by
the balanced activity of excitatory and inhibitory neurons (Reato
et al., 2010).
Interestingly, the lowest field intensities that affect neuronal
activity in vitro are close to the maximum values of fields induced
during transcranial stimulation. This may look like paradoxical
considering that the stimulation parameters and the activity of
the slice can be controlled in great detail. However, the reduced
level of connectivity, the absence of inputs from other brain areas
and the lack of neuromodulators in brain slices is likely to reduce
the sensitivity of neuronal populations to electric fields in vitro.
Therefore, while the use of in vitro preparations is of crucial impor-
tance for understanding how neurons respond to electric fields, the
key differences with in vivo or human experimental settings sug-
gest caution in directly comparing electric field magnitudes.
7. tDCS and models of electric current through the brain
The primary use of ‘‘forward” models of tDCS is to predict the
pattern of electric current through the brain for a given electrode
montage (dose) and a given head anatomy (Ruffini et al., 2013).It is because the relationship between the electrode montage and
current is complex that models provide value in dose design and
optimization. Accurate modeling requires MRI-derived anatomy
preserving gyri-level precision (Datta et al., 2009; Parazzini et al.,
2011, 2012; Bikson and Datta, 2012; Miranda et al., 2013;
Rampersad et al., 2014; Opitz et al., 2015). Simpler geometries
can be used to understand general features of the current distribu-
tion (Miranda et al., 2006, 2009; Faria et al., 2011) and to develop
intuition on the dose design (Dmochowski et al., 2012).
Basic free modeling tools are available,(Truong et al., 2015) as
well as commercial software (Woods et al., 2015). However, cur-
rently advanced modeling requires access to engineering software
(Windhoff et al., 2013). Whole body phantoms for dose calcula-
tions (Christ et al., 2010) are also now available and are used in
modeling studies of tDCS (Parazzini et al., 2011, 2012, 2013a,b,
2014a; Im et al., 2012; Laakso and Hirata, 2013). A detailed
anatomical head model, MIDA, has been recently made available
for public use (http://dx.doi.org/10.1371/journal.pone.0124126;
Iacono et al., 2015).
Models can be used to optimize conventional tDCS approaches
using two large electrodes, noting that such approach will inevita-
bly produce diffuse, if montage-specific, current distributions
(Woods et al., 2014). Models can also be used to leverage High-
Definition tDCS (Datta et al., 2009), or other multi-electrode
approaches for targeting, or to consider inter-individual difference
across the normal adult population (Datta et al., 2012), in obesity
(Truong et al., 2013), across children (Kessler et al., 2013; Gillick
et al., 2014), and in brain injury such as skull defects (Datta
et al., 2010) and stroke (Dmochowski et al., 2013).
Models are ultimately used to select a ‘‘best” montage for a
given indication (Brunoni et al., 2014) or, when possible, an indi-
vidual (Gillick et al., 2014; Kim et al., 2014). Attempts to validate
models have provided direct and indirect support for utility
(Datta et al., 2013; Edwards et al., 2013). Open questions remain
about how to relate predicted current density or electric field dis-
tributions with neurophysiologic, cognitive and behavioral
changes (Rahman et al., 2013, 2014; Ruffini et al., 2014).8. tES ethics
As all research and medical procedures involve human subjects,
tES must comply with ethical principles and standards. Although
the regulatory framework differs among countries, the leading
principles revolve around topics of protection and safety of partic-
ipating subjects, and professional conduct. This in general involves
multiple aspects addressed by a complex system of regulations,
recommendations and principles, for example Good Practices in
Clinical Research, or Code of Federal Regulations in the U.S. Below,
we discuss selected issues highly relevant specifically to ethic per-
taining to tES.8.1. Education and training
Although tES is a user-friendly technique and the operation of
the device, in comparison with other methods of brain stimulation,
is relatively easy, skill development for consistent and safe applica-
tion of tES requires comprehensive, multiple-step training. As tES
has not yet been integrated into medical practice, it is not included
in a formal medical graduate and postgraduate education. Avail-
ability of tES courses/workshops is growing, but they cannot sub-
stitute for comprehensive training. Well-trained tES personnel
should be proficient in the following aspects of tES application
(1) the theoretical background of tES, (2) principles and rationale
of tES use in specific populations, (3) dose, target, and stimulation
protocol determination, (4) selection of subjects, (5) safety evi-
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ration and positioning of the electrodes, preparation and operating
the tES unit, (7) outcome monitoring and recording, including
recording and reporting adverse events. Exposing subjects to tES
delivered by personnel lacking sufficient practice and training
would be a substantial lapse in professional conduct.8.2. Settings and procedures
As the tES technology is rapidly developing, explorations of tES
applications expand to variety of settings. For example, the con-
ventional (1  1) tES is transitioning to clinical practices, and its
modifications with enhanced safety features are being explored
in remote (home-based) settings. In this context, the observance
of principles of responsible professional conduct is of highest
importance. Each setting (e.g., Randomized Clinical Trials, open–
label or compassionate studies, remote delivery at the patient’s
home) requires provisions for safe tES conduct, i.e., specific proce-
dures pertaining to monitoring of clinical status, adverse events
and outcomes, as well as procedures pertaining to an access to
medical assistance in case of unexpected events etc.8.3. Patient/subject selection
A requirement of careful selection of subjects is a mandatory
prerequisite for safe tES conduct. It is understood that tES is being
explored and delivered in populations with various pathologies,
and this is well justified in specific research protocols carried out
by an experienced team in safety-enhanced environment. How-
ever, engaging subjects in tES procedure ad hoc without screening
and careful considerations of conditions and factors that may alter
expected tES outcomes is not consistent with the principles of
responsible professional conduct.8.4. Patient/subject education and informed consent
It is the tES operator responsibility to inform patients on poten-
tial risks and benefits pertaining to tES procedure, and to assure
the subject’s understanding, so that each potential tES participant
can make an informed decision and provide informed consent for
the procedure. In specific cases where decline of cognitive function
is suspected, it is necessary to determine and document if the
patient lack the ability to consent, and to obtain the consent from
the patient’s legal representative/medical proxy. However, inclu-
sion of research participants who lack decisional capacity must
be approved by the regulatory authority (e.g., Institutional Review
Board/Independent Ethics Committee IRB/IEC) and the consenting
procedure must follow an approved study protocol.
Overall, tES has a promising potential for numerous fields of
medicine and various patient-populations who do not respond to
conventional therapies. Compliance with ethical principles in tES
conduct facilitates further development of tES techniques and their
future integration into medical practices.9. Concluding remarks
In this review paper, we deliver guidance for technically sound
application, and interpretation of tES results. Although the tech-
nique is seemingly simple and easy to apply, specific aspects have
to be taken into consideration to obtain reliable results. This over-
view aims to enhance the quality of tES application in future stud-
ies, help to avoid misconceptions and -interpretation, and
therefore improve the quality of scientific work in this field further.Acknowledgements
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